Noninferiority of S-1 to UFT/LV as adjuvant chemotherapy for stage III colon cancer: A randomized phase III trial (ACTS-CC).

Yoshihiko Nakamoto,Megumi Ishiguro,Motoki Yoshida,Koji Ikejiri,Izumi Mochizuki,Hidetaka Mochizuki,Kenjiro Kotake,Shingo Kameoka,Keiichi Takahashi,Toshiaki Watanabe,Masahiko Watanabe,Narikazu Boku,Naohiro Tomita,Yoshihiro Matsubara,Kenichi Sugihara

Noninferiority of S-1 to UFT/LV as adjuvant chemotherapy for stage III colon cancer: A randomized phase III trial (ACTS-CC).

2013

Yoshihiko Nakamoto
Megumi Ishiguro
Motoki Yoshida
Koji Ikejiri
Izumi Mochizuki
Hidetaka Mochizuki
Kenjiro Kotake
Shingo Kameoka
Keiichi Takahashi
Toshiaki Watanabe
Masahiko Watanabe
Narikazu Boku
Naohiro Tomita
Yoshihiro Matsubara
Kenichi Sugihara

3518 Background: The ACTS-CC trial is a phase III trial designed to validate non-inferiority of S-1 to UFT/LV, a standard treatment in Japan as adjuvant chemotherapy for stage III colon cancer. Thi...

Keywords:

Oncology
Pathology
Stage III Colon Cancer
Adjuvant
Internal medicine
Chemotherapy
Medicine
Standard treatment
adjuvant chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations